BPG is committed to discovery and dissemination of knowledge
Observational Study
©The Author(s) 2015.
World J Gastroenterol. Jan 21, 2015; 21(3): 969-976
Published online Jan 21, 2015. doi: 10.3748/wjg.v21.i3.969
Table 1 Patient baseline characteristics n (%)
CharacteristicsPatients assessed for aberrant RHA (n = 458)Patients assessed for CAS(n = 181)
Age, (yr)57.2 ± 12.957.3 ± 13.6
Male242 (52.8)102 (56.4)
Unresectable disease82 (17.9)82 (45.3)
Diagnosis
Pancreatic adenocarcinoma291 (63.5)150 (82.9)
Pancreatic cystic neoplasm34 (7.4)6 (3.3)
Pancreatic neuroendocrine tumor14 (3.1)4 (2.2)
Ampullary adenocarcinoma31 (6.8)9 (5.0)
Duodenal adenocarcinoma19 (4.1)1 (0.6)
Others69 (15.1)11 (6.1)
Surgery
Whipple318 (69.4)87 (48.1)
PPPD58 (12.7)12 (6.6)
Palliative bypass13 (2.8)4 (2.2)


Write to the Help Desk